G J Finlay|R J Booth|J Marbrook - JoVE Visualize

Showing results (91-100 of 144) with videos related to

Pageof 15

Sort By:

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

In vitro methods for screening agents with an indirect mechanism of antitumour activity: xanthenone analogues of flavone acetic acidL M Ching, G J Finlay, W R Joseph, et al.

Journal of the National Cancer Institute|August 1, 1987

Resistance of cultured Lewis lung carcinoma cell lines to tiazofurinG J Finlay, L M Ching, W R Wilson, et al.

Journal of the National Cancer Institute|April 20, 1988

Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effectG J Finlay, G P Smith, L M Fray, et al.

European Journal of Cancer (Oxford, England : 1990)|February 1, 1997

A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrineB C Baguley, F Leteurtre, J F Riou, et al.

European Journal of Cancer (Oxford, England : 1990)|December 9, 1997

Cellular responses to methyl-N-[4-9-acridinylamino)-2-methoxyphenyl] carbamate hydrochloride, an analogue of amsacrine active against non-proliferating cellsN Moreland, G J Finlay, M Dragunow, et al.

Immunology and Cell Biology|December 1, 1993

T cell receptor polymorphisms in Caucasians and PolynesiansW G Abbott, P L Tan, M A Skinner, et al.

Psychological Medicine|April 28, 1999

Psychological influences on the perception of immune functionK J Petrie, R J Booth, H Elder, et al.

Australian Veterinary Journal|October 7, 2000

Disseminated haemangiosarcoma in an eastern barred bandicoot (Perameles gunnii)K B Bodley, R J Booth, J Samuel, et al.

Journal of Psychosomatic Research|February 8, 2000

Positive effects of illness reported by myocardial infarction and breast cancer patientsK J Petrie, D L Buick, J Weinman, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1993

In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistanceG J Finlay, E Marshall, J H Matthews, et al.

Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:

Pageof 15

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

In vitro methods for screening agents with an indirect mechanism of antitumour activity: xanthenone analogues of flavone acetic acidL M Ching, G J Finlay, W R Joseph, et al.

Journal of the National Cancer Institute|August 1, 1987

Resistance of cultured Lewis lung carcinoma cell lines to tiazofurinG J Finlay, L M Ching, W R Wilson, et al.

Journal of the National Cancer Institute|April 20, 1988

Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effectG J Finlay, G P Smith, L M Fray, et al.

European Journal of Cancer (Oxford, England : 1990)|February 1, 1997

A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrineB C Baguley, F Leteurtre, J F Riou, et al.

European Journal of Cancer (Oxford, England : 1990)|December 9, 1997

Cellular responses to methyl-N-[4-9-acridinylamino)-2-methoxyphenyl] carbamate hydrochloride, an analogue of amsacrine active against non-proliferating cellsN Moreland, G J Finlay, M Dragunow, et al.

Immunology and Cell Biology|December 1, 1993

T cell receptor polymorphisms in Caucasians and PolynesiansW G Abbott, P L Tan, M A Skinner, et al.

Psychological Medicine|April 28, 1999

Psychological influences on the perception of immune functionK J Petrie, R J Booth, H Elder, et al.

Australian Veterinary Journal|October 7, 2000

Disseminated haemangiosarcoma in an eastern barred bandicoot (Perameles gunnii)K B Bodley, R J Booth, J Samuel, et al.

Journal of Psychosomatic Research|February 8, 2000

Positive effects of illness reported by myocardial infarction and breast cancer patientsK J Petrie, D L Buick, J Weinman, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1993

In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistanceG J Finlay, E Marshall, J H Matthews, et al.

Pageof 15